translate English to French: Dr. Covens is also lead investigator of the study and a surgical oncologist at Toronto Sunnybrook Regional Cancer Centre. http://www.sunnybrook.ca Clinical Trials Stem Cell Therapeutics Corp. announces positive interim results Stem Cell Therapeutics Corp. (Calgary) announces positive interim results from its currently enrolling Phase IIa- Safety Trial study 'Beta-hCG + Erythropoietin in Acute Stroke'.
Le Dr Covens est également investigateur principal de l'étude et chirurgien oncologue au Toronto Sunnybrook Regional Cancer Centre. http://www.sunnybrook.ca Essais cliniques Stem Cell Therapeutics Corp. anonnce des résultats provisoires positifs Stem Cell Therapeutics Corp. (Calgary) a annoncé des résultats provisoires positifs pour son étude d'innocuité de phase IIa pour laquelle le recrutement est en cours, intitulée 'Beta-hCG + Erythropoietin in Acute Stroke'.